Doing some policy research? Need some background materials? You've come to the right place.
Note: Documents in the library are organized by issue area — and PDFs require Adobe Reader (free download/upgrade available).
We write in response to the Advance Notice of Proposed Rulemaking in docket number 2005N-0345 regarding Barr Laboratories’ application for over-the-counter (OTC) status for Plan B® emergency contraception (EC). Given the overwhelming recommendation of the FDA’s independent expert advisory committees and professional staff that Plan B® is safe and effective for women of all ages and should be made available OTC, we strongly urge you to stop the unnecessary rulemaking process and make the product available without restrictions for women of all ages without further delay.
I am writing to express strong support for passage of H.R. 810, the Stem Cell Research Enhancement Act of 2005, which would expand the ability of researchers to pursue federally funded stem cell research. H.R. 810 would promote medical research that is critical to women both as patients and caregivers.
Access to safe and effective contraception is essential to women’s reproductive health. Consistent with that goal, the National Partnership submits this testimony in support of SB 541, a bill that would allow Maryland women to obtain emergency contraception – also known as the “morning after pill – directly from a trained, licensed pharmacist pursuant to a written protocol developed with a physician.
We stand for healthy women and families. We stand for access to basic health care, including birth control, emergency contraception, sex education, STD testing and treatment, prenatal care, and abortion. we stand for medical privacy. We stand for women’s lives. We stand on moral ground.
Wow! What a thrill it is to look out on this sea of pro-choice faces, to know that hundreds of thousands of people have come from all over the country – all over the world – to stand up for women’s lives. It’s been a long time since America’s pro-choice majority has dominated thescene. Too long. But we’re here today to change that. With this march, we begin a new era.
Before you move on to your next challenge, we request that you make one more decision that upholds the credibility and integrity of the Food and Drug Administration, which you have so ably led. We believe it is important, in your current capacity as FDA Administrator, to make a decision on the Plan B over-the-counter (OTC) application based solely on the scientific evidence and the benefits for women’s health and wellbeing.
The National Partnership for Women & Families strongly urges you to oppose any amendments to the FY 2008 Labor, Health and Human Services, and Education appropriations bill filed by Senator David Vitter (R-LA) intended to render health clinics that provide abortion care with non-federal dollars, under almost all circumstances, ineligible for funding through the bill.
The undersigned organizations are writing to strongly object to the “Provider Conscience” regulation proposed on August 26, 2008 by the Department of Health and Human Services (HHS). The proposed regulation is unnecessary, threatens to significantly undermine patients’ access to critical health care services and information, and could negatively impact scientific research.
The National Partnership for Women & Families strongly supports allowing research using Somatic Cell Nuclear Transfer (SCNT), commonly known as therapeutic cloning. The purpose of this technology is to develop treatments for diseases and give millions of people access to life-saving therapies using their own DNA.
On behalf of the American College of Obstetricians and Gynecologists (ACOG), I am writing to express our absolute objection to a draft proposed regulation that would severely restrict women’s access to birth control, among a number of other serious issues. We strongly urge you to abandon any further efforts to move forward with this proposal.
Chlamydia remains the most commonly reported infectious disease in the United States, yet up to 90% of women and a large percentage of men with chlamydial infection are asymptomatic. If left untreated, chlamydia can cause severe health consequences, including pelvic inflammatory disease (PID) – a leading cause of infertility.
Section 2707(a) of the Patient Protection and Affordable Care Act (ACA) requires that all new health insurance plans in the individual and small group markets, including qualified health plans sold through health insurance exchanges, provide at least the Essential Health Benefits (EHB) package. Section 1302(b) of the ACA identifies a core set of ten categories to be included in the EHB, one of which is maternity and newborn care.
Contraception is a critical component of basic health care for women. Contraception allows women to safely plan their pregnancies, which research has proven is critical to ensuring healthy outcomes for both mother and child.
The 1973 U.S. Supreme Court decision in Roe v. Wade, 410 U.S. 113, appeared to ensure that American women would have access to abortion, ruling out any legislative interference in the first trimester of pregnancy and putting limits on abortion restrictions that could be passed during the later stages of pregnancy. The decision followed a long history of women seeking and obtaining abortions – but with a shift in the legal status of the procedure over time.
|Items 61 - 74 of 74||Previous||1||2||3||4|